Rocket Lab (RKLB) stock has dropped by 27.9% in less than a month, declining from $69.27 on October 15, 2025, to $49.97 currently. What lies ahead?
Rocket Lab USA NASDAQ: RKLB delivered a strong third quarter, and the market wasted no time responding. Shares climbed in after-hours trading after the company posted record revenue, showing that demand in both Electron launch services and Space Systems remains firmly in place.
Rocket Lab (RKLB)'s shares soared over 100% since mid-May, driven not only by consistent revenue growth but also by a near doubling in investor optimism.
Rocket Lab Corporation (RKLB) delivered record Q3 results, with strong revenue growth, a $1.1 billion backlog, and big international contract wins. RKLB's Q3 revenue beat expectations, EPS loss narrowed, and management guided for continued gross margin improvement and robust Q4 growth. Neutron rocket development and Space Systems segment progress highlight RKLB's innovation, operating leverage, and ample liquidity for future expansion.
Rocket Lab delivered record Q3 revenue of $155.1M, up 48% YoY, and beat EPS and revenue estimates, driving a 7% stock gain. RKLB's growth is fueled by strong Electron launch demand, aggressive acquisitions, and expanding space systems, with improved margins and narrowing losses. The Neutron rocket launch is rescheduled to Q1 2026, reflecting prudent engineering; infrastructure and R&D milestones are progressing well.
Rocket Lab delivered record Q3 revenue of $155M and a 37% gross margin, beating expectations and signaling improving profitability as launch scale increases. RKLB secured 17 new Electron launch contracts, completed the $325M Geost acquisition, and issued strong Q4 guidance with continued margin expansion and revenue growth. Management is prioritizing disciplined, thorough testing for Neutron's 2026 launch, reinforcing reliability and long-term execution over speed, which supports investor confidence.
Rocket Lab Corporation (RKLB) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.05 per share. This compares to a loss of $0.1 per share a year ago.
Rocket Lab (NASDAQ: RKLB) beat on both revenue and earnings in Q3 while posting record gross margins, sending the stock surging 8.3% in after-hours trading.
RKLB's strong launch growth and solid bookings are likely to lift Q3 results, but high costs and rich valuation could test investor patience.
Rocket Lab Corporation (RKLB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
After a decisive breakout through resistance near $55, shares of Rocket Lab USA NASDAQ: RKLB have finally taken a breather. With the company set to report earnings in November, investors might now be asking the key question: Is this pullback a chance to buy, or a signal to stay cautious?
Rocket Lab is up 500% over the last 12 months. With Neutron's debut fast approaching, investors are piling in to get a piece of the action. Despite valuation concerns, I think RKLB remains a long-term buy.